Related Experiment Video

Updated: Dec 12, 2025

Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
05:42

Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements

Published on: January 7, 2019

32.3K

Perioperative Management of Children on Ketogenic Dietary Therapies

Zacherie R Conover1, Afsaneh Talai2, Katherine S Klockau3

  • 1From the Departments of Anesthesiology.

Anesthesia and Analgesia
|August 10, 2020
PubMed

Insights

Ketogenic diet therapy (KDT) is crucial for children with drug-resistant epilepsy. Anesthetic management must maintain ketosis to prevent seizures during surgery.

Area of Science:

  • Pediatric Anesthesiology
  • Neurology
  • Dietary Therapy

Background:

  • Ketogenic diet therapy (KDT) is an established treatment for drug-resistant epilepsy in children.
  • Interest in KDT is growing, leading to more pediatric patients requiring anesthesia.
  • Maintaining ketosis perioperatively is vital to prevent seizures in these children.

Purpose of the Study:

  • To review the clinical aspects of KDT in pediatric patients.
  • To provide guidance on anesthetic management for children on KDT.
  • To highlight the importance of maintaining ketosis during the perioperative period.

Main Methods:

  • Literature review of KDT in pediatric epilepsy.
  • Analysis of clinical indications, contraindications, and monitoring of KDT.
  • Summary of anesthetic management recommendations for KDT patients.
  • Inclusion of a table detailing carbohydrate content in anesthetic drugs.

Main Results:

  • KDT is effective for drug-resistant epilepsy and other neurologic disorders.
  • Perioperative management requires careful attention to maintain ketosis.
  • Inappropriate management increases seizure risk in children on KDT.
  • Anesthetic drugs can contain carbohydrates that disrupt ketosis.

Conclusions:

  • Pediatric anesthesiologists must be familiar with KDT principles.
  • Perioperative anesthetic strategies should prioritize maintaining ketosis.
  • Understanding carbohydrate content in anesthetic agents is essential for safe patient care.

More Related Videos

Guidelines for Elective Pediatric Fiberoptic Intubation11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

18.2K
Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs08:58

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Published on: October 31, 2025

406

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
111
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
147
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
175
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
199
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
471